Dr. Lisa K. Chipps, MD, MS

Dr. Chipps practices at Golden State Dermatopathology in Walnut Creek, California.

Dr. Chipps' NPI, 1689720278, was assigned on January 26, 2007. Dr. Chipps graduated from Keck School of Medicine of USC in 2004. Dr. Chipps' California license number on file is A93058.

Dr. Chipps' primary practice is Golden State Dermatopathology, at 370 N Wiget Ln, Ste 250, Walnut Creek, CA 94598. The practice phone is (925) 278-7592.

Dr. Chipps' primary practice is Golden State Dermatopathology in Walnut Creek, California. The medical group on file is Golden State Dermatology. Dmand AI also links Dr. Chipps to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Chipps' employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chipps practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Chipps' primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Chipps is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Chipps' licenses on file in 3 states: California, Colorado and Hawaii.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and joint cyst among the conditions Dr. Chipps treats.

CMS data shows 4,071 Medicare services from Dr. Chipps across 22 procedure codes in 2024, for 737 Medicare patients. Medicare paid $444,125 for them.

CMS counts 737 Medicare patients who saw Dr. Chipps in 2024. The largest group is 75 to 84, with 331 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chipps' median patient age at 69, with 53% women.

In 2024, Dr. Chipps wrote 383 Medicare Part D claims for 196 patients. 97% of them were for generic drugs. CMS names the drug for 288 of them, across 10 drugs with 11 or more claims each, at $7,570 in total drug cost. In 2023, CMS named 262 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Chipps for performance year 2024, reported as part of a group. Dr. Chipps accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 693 procedures of removal of skin lesions by Dr. Chipps, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Chipps, published from 2018 to 2019. The most frequent topics are Carcinoma, Squamous Cell, Skin and Skin Neoplasms. Dr. Chipps has published most often in J Drugs Dermatol. Dr. Chipps' most frequent co-authors are Jason Joshua Bentow, MD, Consuelo Veronica David, MD and David M. Ozog, MD.

Dmand AI links Dr. Chipps to 2 clinical trials. Conditions studied include Cicatrix, Facies and Disease Attributes.

CMS Open Payments shows 295 general payments to Dr. Chipps from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Allergan Inc. paid the most, $1,970.

Dmand AI lists 7 awards for Dr. Chipps, most recently Vice President in 2024.

Dr. Chipps graduated from Keck School of Medicine of USC in 2004. Dr. Chipps is a member of AACS, AAD, American College of Mohs Surgery and ASDS.

Dr. Chipps is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.